Baszucki Group Launches Two Initiatives Exploring Ketogenic Therapy for Youth with Bipolar Disorder Baszucki Group has announced the launch of two innovative research initiatives aimed at exploring the effectiveness of ketogenic therapy for children and adolescents with bipolar disorder. These…
Ensitrelvir Demonstrates Effectiveness in Preventing COVID-19 as Post-Exposure Prophylaxis: Results from the SCORPIO-PEP Phase 3 Trial SCORPIO-PEP Phase 3: Ensitrelvir First Oral Antiviral to Prevent COVID-19 as Post-Exposure Prophylaxis At the Conference on Retroviruses and Opportunistic Infections 2025, Shionogi &…
Oligomerix Publishes Preclinical Results of Oral Alzheimer’s Drug Study Oligomerix, Inc., a pioneering clinical-stage biotechnology company focused on developing protein self-association inhibitors for Alzheimer’s disease (AD) and related neurodegenerative disorders, has announced the publication of a preclinical study demonstrating the…
ARM & HAMMER Baking Soda Joins the 2025 STEM Festival to Ignite Curiosity in STEAM ARM & HAMMER Baking Soda is gearing up for an exciting and impactful presence at the 2025 STEM Festival, committed to supporting its mission of…
Free Heart & Kidney Health Screenings Available in Jacksonville, March 17-19 Care Access, a leading health and research organization, is offering free Heart & Kidney Community Health Screenings to Jacksonville residents from March 17-19. These screenings are part of an…
InTandem Capital Partners Invests in Clinilabs to Accelerate CNS Drug and Device Development InTandem Capital Partners, a private equity firm specializing in healthcare services, has announced a strategic partnership with Clinilabs, a global full-service contract research organization (CRO). This collaboration…
IQVIA Recognized as a Leader in IDC MarketScape’s 2024 Assessment for Decentralized Clinical Trial Technologies and Consulting Services IQVIA, a global leader in AI-powered analytics, technology solutions, and clinical research services for the healthcare and life sciences industries, has been…
Ventus Therapeutics Doses First Patient in Phase 2a Trial of VENT-02 for Parkinson’s Disease Ventus Therapeutics, a clinical-stage biopharmaceutical company, has announced that the first patient has been dosed in its Phase 2a clinical trial evaluating VENT-02 in patients with…
DuPont Water Solutions Launches WAVE PRO for Ultrafiltration Modeling DuPont Water Solutions has introduced WAVE PRO, an advanced online modeling tool designed to optimize ultrafiltration (UF) water treatment applications. This tool is applicable across a range of water treatment needs,…
Noramco Group Announces $25 Million Investment in Halo Pharma’s Whippany Facility for Sterile Injectable Manufacturing The Noramco Group, a prominent North American provider of integrated Active Pharmaceutical Ingredient (API) and drug product supply chain services, has made a strategic $25…
Care Access Acquires CEMEC to Expand Clinical Research in Brazil and Latin America Care Access, a global healthcare and research company, has announced the acquisition of Centro Multidisciplinar de Estudos Clínicos (CEMEC), one of Brazil’s leading clinical research centers. Known…
Ionis Pharmaceuticals, Inc. has announced that its partnership with AstraZeneca has led to the approval of WAINZUA (eplontersen) by the European Union (EU) for the treatment of hereditary transthyretin-mediated amyloidosis (hATTR) in adults with stage 1 or stage 2 polyneuropathy.…